Reversed-phase ultra-high-performance liquid chromatography (RP-UHPLC) was used for the separation of recombinant human growth hormone (rhGH) variants. A bridged ethylene hybrid silica C18 column was used at 378 8 8 8 8C. The composition and temperature of the mobile phase were optimized for the separation. An isocratic elution, with approximately 46% acetonitrile in 25 mM potassium borate buffer ( pH 8.5), was found to give superior selectivity in comparison with commonly used mobile phases. The method separated eight rhGH variants: (i) di-oxy Met14/Met125 sulfoxide, (ii) Met125 sulfoxide, (iii) Met14 sulfoxide, (iv) mono-deamidated (Asn149 ! Asp149 or Asn152 ! Asp152), (v) di-deamidated (Asn149 ! Asp149 and Asn152 ! Asp152), (vi) clip (Thr142-Tyr143), (vii) desPhe1 and (viii) trisulfide (Cys182-SSS-Cys189) from each other and from the native rhGH. Characterization of the purified variants was conducted by liquid chromatography-mass spectrometry tryptic mapping. The novel mobile phase, in combination with the UHPLC system, generated a significantly higher resolution than previously reported reversed-phase LC methods, including pharmacopoeal methods, for analyzing rhGH.
Introduction
Human growth hormone (hGH) consists of a single polypeptide chain (191 amino acid residues) with two disulfide bridges and a mass of 22 kDa (1) . Modifications of recombinant hGH (rhGH) may arise during the fermentation and purification processes or during storage of the protein, which can influence the biological activity of the hormone. The deamidation of rhGH (Asn149 ! Asp149 and Asn152 ! Asp152) (2) is a common modification that is induced at ambient or elevated temperature at neutral or slightly alkaline pH. Under acidic conditions, the dehydration of normal Asp130 can yield isoAsp130, and both normal and isoAsp130 rhGH variants have been separated by cation-exchange chromatography, as communicated by a conference poster (3) . Methionine residues, at positions 14 and 125, are prone to oxidation (2, 4, 5) , whereas the only remaining methionine (Met170), located in the interior of the protein (6) , is not oxidized in the native peptide (7) . Other variants of rhGH have been described, including dimers (8) , des-Phe1 (2) and desPhe1-Pro2 rhGH (9) , a clipped variant (Thr142-Tyr143) (2) , trisulfides [Cys182-SSS-Cys189 (10) (11) and Cys53-SSS-Cys165 (12) rhGH], and a thioether variant (Cys182-Cys189) (13) .
Reversed-phase liquid chromatography (RPLC) is used because of its high resolution. It is also the most often used LC technique for analyzing different variants of rhGH. Other techniques, such as capillary LC (9) and non-porous particle (14) methods have also been used. In addition, other LC techniques have been used to analyze various variants of rhGH; for example, ion exchange chromatography (IEX) and hydrophobic interaction chromatography (HIC) have been used for the analyses of deamidated variants (2) and the rhGH trisulfide (Cys182-SSS-Cys189) (15) , respectively. Capillary zone electrophoresis (CZE) methods have been used to identify different variants of rhGH, including deamidated variants and variants that cannot be separated by LC methods, including a 20 kDa (16) variant and a His18 ! Gln18 rhGH mutant variant (17) . A review of methods for analyzing rhGH variants is provided by Bayol and collaborators (18) . The reported LC methods for separating rhGH variants have all included the coelution of several rhGH variants. Therefore, a need exists for an improved analytical LC method to analyze various rhGH variants. In 2004, ultra-high-performance liquid chromatography (UHPLC) was introduced for commercial use. This technique offers improved resolution due to the increased theoretical plate number obtained by using sub-2 mm particles at pressures of more than 400 bar. The present study describes a reversed-phase UHPLC (RP-UHPLC) method that allows for the separation of eight rhGH variants from each other and from the native rhGH. The potassium borate-acetonitrile mobile phase offered significantly higher selectivity than several other commonly used buffers-mobile phases. The new mobile phase with the UHPLC system resulted in significantly higher resolution than in previously described methods. Characterization of the previously purified rhGH variants was performed by liquid chromatography-mass spectrometry (LC -MS) tryptic mapping date. This is the first report in which all of these rhGH variants are resolved in one method as separate peaks, or in which a borate buffer or a UHPLC system has been used for separating rhGH variants by RPLC.
Experimental

Materials
A laboratory sample of recombinant rhGH and purified rhGH variants was obtained from Pfizer Health AB (Stra¨ngna¨s, Sweden). Acetonitrile (LiChrosolv), potassium phosphate, boric acid and affinity purified trypsin (catalogue number 8444) were from Merck (Darmstadt, Germany), and 1-propanol (Chromasolv), tris(hydroxymethyl)aminomethane (Tris) and trifluoroacetic acid (TFA) were from Sigma-Aldrich (St. Louis, MO). Ammonium bicarbonate was from Fluka (Buchs, Switzerland).
Analyzed rhGH variants
The production, purification and characterization of the rhGH variants were previously performed at Pfizer, as summarized in the following. The Met-sulfoxide derivatives were produced by incubating rhGH at 08C in the presence of hydrogen peroxide, and the reaction was stopped by the addition of catalase (2, 19) . Finally, RPLC was used to separate the Met14 and Met125 sulfoxides and the dioxidized Met14/Met125 rhGH variants. Deamidation was performed by incubating rhGH in aqueous ammonium bicarbonate at 378C (2, 19) , followed by the separation of the mono-(Asn149 ! Asp149 or Asn152 ! Asp152) and di-deamidated (Asn149 ! Asp149 and Asn152 ! Asp152) rhGH variants by anion exchange LC using an Ä KTA system (GE Healthcare, Uppsala, Sweden). The desPhe1 rhGH was obtained from the production process for rhGH (Pfizer), from a side fraction at an early chromatographic step during the purification procedure. This fraction was further purified by chromatofocusing using the Ä KTA system to obtain the desPhe1 rhGH variant. The rhGH trisulfide (Cys182-SSS-Cys189) was produced by the addition of sodium sulfide, as previously described (11, 20) , and followed by purification using a phenyl HIC column (15) . The clip (Thr142-Tyr143) variant was from a side fraction that eluted at an early step in the rhGH purification process, which was further purified by the phenyl HIC column (15) . All purified variants were freeze-dried, stored at -708C and reconstituted with water before use. Characterization was performed by LC-MS tryptic mapping and additional analytical techniques. The purities of these variants were determined to be 81 -97% by RPLC, HIC and other methods.
The previously performed characterization was briefly repeated in the present work to obtain confirmation. The rhGH forms were analyzed, both separately and spiked to a native rhGH laboratory sample at a concentration of 0.5 to 10% of each rhGH form.
RP-UHPLC
The rhGH samples were analyzed using RP-UHPLC on an Acquity ultra-performance liquid chromatograph (UPLC) with Empower 2 software and a bridged ethylene hybrid silica sorbent (BEH) 300, C18 column (1.7 mm, 300 Å , 150 Â 2.1 mm i.d.), all from Waters (Milford, MA). The analytical column was equilibrated with approximately 46% (v/v) acetonitrile in 25 mM potassium borate, pH 8.5, at 378C. The injection volume of rhGH (1 mg/mL) was 2 mL. The flow rate was 0.3 mL/min and detection was conducted by measuring the ultraviolet (UV) absorbance at 210 nm, unless otherwise indicated. During optimization of the method, the analysis was evaluated at 30 -558C. Potassium phosphate, pH 7.4, was also tested as the buffer component in the mobile phase. In addition, a method that was essentially described by the United States Pharmacopeia (USP) and the European Pharmacopoeia (EP) (21, 22) was used during the method development, using a mobile phase consisting of 35.5 mM Tris -HCl, pH 7.5, with approximately 29% 1-propanol, at a temperature of 458C, with detection of the absorbance at 220 nm. The USP/EP method, however, states that a C4 column is used. Because of the increased backpressure, the flow rate was reduced to 0.2 mL/ min in the USP/EP method. The organic percentage in the mobile phases was slightly adjusted to obtain approximately the same retention factors.
LC-MS tryptic peptide mapping
Characterizations of the purified rhGH variants were conducted to confirm the previous characterizations. The preparations of the eight rhGH variants, together with a laboratory sample (.95% pure) of rhGH, were incubated in 1% (w/v) ammonium bicarbonate and trypsin for 4 h at 378C. The total incubation volume was 120 mL with 0.6 mg/mL rhGH, and the enzyme to substrate ratio was 1:35 by weight. The digestion was stopped by the addition of 2 mL of 85% phosphoric acid. The trypsin-digested rhGH samples were analyzed using RP-UHPLC with the same system and column as described previously. The mobile phase A was 0.05% TFA in water and the mobile phase B was 0.04% TFA in acetonitrile. The injection volume was 5 mL and elution was conducted by using a gradient (0-1 min 0% B, 1-4 min 0 -1% B, 4 -18 min 1 -18% B, 18-30 min 18 -20% B, 30 -53 min 20 -55% B, 53 -55 min 60% B and 55 -60 min 0% B). The flow rate was 0.3 mL/min with a column temperature of 408C and detection by absorbance at 214 nm. The intact rhGH variants were also analyzed by LC-MS.
The eluate from the LC was analyzed online by MS using a XEVO G2 quadrupole time-of-flight mass spectrometer (QTOF-MS) with an electrospray interface (ESI), together with Mass Lynx software (Waters). The QTOF was set as follows: positive mode, capillary 3.0 kV, sampling cone 30 V, extraction cone 4.0 V, source temperature 1208C, desolvation temperature 2808C, cone gas flow 1 L/h and desolvation gas flow 800 L/h. Spectra were recorded from 50 -2,000 (scan time 0.3 s) and 500-3,000 m/z (scan time 0.5 s) for peptides and intact proteins, respectively.
Results and Discussion
In this work, a UHPLC method was developed for analyzing several modified variants of rhGH. Figure 1 shows results from the method development, including the testing of different column temperatures and the use of acetonitrile and 1-propanol as the organic solvents in the mobile phase. TrisHCl with 1-propanol in the mobile phase at 458C, according to USP/EP (21, 22) , and a potassium phosphate -acetonitrile mobile phase were also evaluated. A column temperature of 378C, using the mobile phase with 25 mM potassium borate ( pH 8.5) and acetonitrile resulted in superior selectivity and resolution, because all eight rhGH variants were separated from each other and from the native rhGH. The influence of temperature on the selectivity was significant; for example, at 358C, the Met125 and Met14 sulfoxide variants of rhGH coeluted, whereas the clip and di-oxidized variants were well resolved. At 398C, the clip and the di-oxidized rhGH variants coeluted, and at 428C, the elution order of these two rhGH variants was reversed, in comparison to 378C. Thus, the method is sensitive to small temperature fluctuations and accurate and reliable control of the column oven temperature is necessary.
Isocratic elution has been shown to be the most effective method for separating rhGH variants by RPLC, and this has been used in the pharmacopoeal methods (USP and EP) and in many reports (4, 5, 8, 14, 19, 23) . The use of a mobile phase with propanol (typically 1-propanol) as the organic modifier, combined with Tris buffers, have been used in USP and EP methods (21, 22) and by several authors (4, 8, 23) , and propanol-phosphate (5, 14, 19) and acetonitrile -phosphate (2, 5, 12) have also been used. In developing the present method, several other buffer components and various pHs were tested, in addition to gradient elution; however, these , with 1-propanol at 458C, using the UHPLC column according to USP/EP conditions, with flow rate and detection at 0.2 mL/min and 220 nm (E); a mobile phase of 25 mM potassium phosphate ( pH 7.4), with acetonitrile, at 378C (F). The flow rate and detection was 0.3 mL/min and by absorbance at 210 nm, respectively. Injection volume was 2 mL of rhGH, 1.0 mg/mL. All eight modified variants of rhGH were individually spiked to 1% in the rhGH laboratory sample. The variants are indicated in the figure (based on individual injections) as follows: (1) clip (Thr142-Tyr143), (2) di-oxy Met14/Met125 sulfoxide, (3) Met125 sulfoxide, (4) Met14 sulfoxide, (5) di-deamidated (Asn149 ! Asp149 and Asn152 ! Asp152), (6) trisulfide (Cys182-SSS-Cys189), (7) mono-deamidated (Asn149 ! Asp149 or Asn152 ! Asp152), and (8) desPhe1 rhGH. The largest peak in the chromatograms is the rhGH native form. The small peak eluting at approximately 12 min in Figure 1E was also observed in the corresponding water blank. The chromatogram in Figure 1B represents the optimized method. Further details are provided in the paper.
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were not successful. No reported methods have been found in which borate buffers were used in the RPLC of rhGH. Neither the method similar to the USP/EP method (458C) or the phosphate -acetonitrile mobile phase method (378C) resulted in high selectivity or resolution. For example, the mono-deamidated rhGH and the desPhe1 variants coeluted with the primary rhGH peak in both methods. When the method similar to the USP/EP method was tested, using the same mobile phase composition ( propanol-Tris) and temperature in combination with the C18 BEH column, five rhGH variants coeluted with the primary peak, and the clipped rhGH eluted last in the chromatogram (Figure 1 ). The method used in this study does differ from the USP/EP method in several respects; in particular, a C4 column is used in the USP/EP method; in addition, the USP/EP method is known to be highly column-specific. In contrast, when acetonitrile was used in the mobile phase at 378C, the clip rhGH peak eluted first. For the tested methods, the selectivity and resolution were superior with the novel borateacetonitrile mobile phase method used at 378C. In addition, the analysis time for this UHPLC method was short, only 30 min.
When the rhGH laboratory sample spiked with 1% of each of the purified rhGH variants was analyzed on six occasions, the optimized method resulted in an intermediate precision below 11% relative standard deviation (RSD) for all eight rhGH variants (Table I ). Figure 2 shows representative chromatograms of the unspiked and spiked rhGH laboratory sample and the individual rhGH variants analyzed by the optimized method. The retention times for the rhGH variant samples (0.1 mg/mL) were slightly longer than the corresponding retention times for the spiked samples with a total protein concentration of 1.0 mg/mL, reflecting the differences in sample load. The linearity (r 2 ) of the added rhGH forms was !0.995 (n ¼ 5, with slopes of 0.6 -1.1 when the percent observed variant content was plotted versus the theoretical variant content) in the range of 0.5 -10% total protein concentration for each rhGH variant that was spiked in the rhGH laboratory sample. Accuracy was calculated from the difference between the observed values for the spiked rhGH laboratory samples with 1.0 and 2.0% of each rhGH variant. The accuracies, measured as percent recovery, were 60-130% for all rhGH variants (Table I ). The peak areas from clip (Thr142-Tyr143) rhGH were slightly lower than for the other variants, which was likely attributable to the peak eluting shortly after the void peak, causing a slight disturbance (Table I) . These results indicate acceptable intermediate precision, linearity and accuracy at low levels of rhGH variants when analyzed by the optimized method. The detection limit was not rigorously investigated; however, distinct increased peaks, compared with the unspiked rhGH laboratory sample, were observed when the sample was spiked with 0.5% of each variant (Figure 2) .
The USP (21) and the EP (22) describe the analysis of rhGH by isocratic C4 RPLC with a mobile phase consisting of 29% 1-propanol and 35.5 mM Tris/HCl, pH 7.5, at 458C, with detection by absorbance at 220 nm. A neutral pH in the RPLC analysis of rhGH variants was also used by others to obtain an improved resolution (5, 19, 23) . In the analysis of rhGH described in this study, a C18 column with a mobile phase of pH 8.5 was empirically chosen using a potassium borate buffer. A variety of mobile phase pH ranges was initially evaluated before settling on pH 8.5 for this work. The use of a mobile phase at pH 8.5 is supported by the work of Tojo and co-workers, who reported that a pH of 8.5 resulted in better Figure 2 . The selectivity of the optimized method. The eight modified variants of rhGH were individually spiked in the rhGH laboratory sample with a total protein concentration of 1 mg/mL to: 0.5% (A); 2% (B). The following samples were analyzed separately: the rhGH laboratory sample (C); clip (Thr142-Tyr143) (D); di-oxy Met14/Met125 sulfoxide (E); Met125 sulfoxide (F); Met14 sulfoxide (G); di-deamidated (Asn149 ! Asp149 and Asn152 ! Asp152) (H); trisulfide (Cys182-SSS-Cys189 (I); mono-deamidated (Asn149 ! Asp149 or Asn152 ! Asp152) (J); desPhe1 rhGH (K); water blank (L). The numbering of peaks and a short method description are given in Figure 1. resolution than pH 7.5 by RPLC in the separation of rhGH deamidated variants and native rhGH using a C18 column (24) . According to the column manufacturer, pH 1 -12 is tolerated by the BEH UHPLC column used in this study. Both 1-propanol and acetonitrile were separately tested as organic modifiers in the mobile phase, with acetonitrile demonstrating the best selectivity and resolution. Acetonitrile is usually the preferred organic phase in LC, based on its physical properties such as low viscosity, which offers a high diffusion rate and higher resolution, especially for high molecular mass compounds such as proteins. In contrast, propanol, with a significantly higher viscosity, results in more peak-broadening. Both acetonitrile and borate have lower UV cutoffs than 1-propanol and TrisHCl, which are used in the USP/EP method. This allows for detection by absorbance at 210 nm, which gives a high response and a low baseline noise. Borate and phosphate have the lowest UV cutoffs of the most commonly used LC buffers, which is why these buffers were the focus of this evaluation. Canova-Davis and collaborators found that 1-propanol was more effective than acetonitrile for the RPLC separation of Met14 sulfoxide rhGH and native rhGH, although acetonitrile was more effective for separating Met14 and Met125 sulfoxide variants of rhGH when using a polymer column with a phosphate buffer mobile phase (5). The differences observed in the results of this study and previous results (5) can be explained by several factors, including differences in the column packing material, buffer components and pH.
LC-MS of intact proteins and tryptic fragments was conducted to locate the types and sites of the modifications (Figure 3 and Tables II -III) . The difference observed for the mass of intact rhGH native protein and the evaluated variants are provided in Table II . The tryptic cleavage of the oxidized rhGH variants gave decreased retention times for both of the T2 and T11 fragments that were identified as the oxidized (þ16 Da in mass) T2 and T11 (Table III) , which is consistent with single oxidations. The oxidized T11 fragment eluted in two distinct peaks (at 21.8 and 22.2 min) with exactly the same m/z values; this may be due to different conformations of the same oxidized peptide. The T2 peak was not completely resolved from the previous peak and there were some minor disturbances in the tryptic map chromatograms; however, this did not cause any problems in the QTOF-MS analysis. In a corresponding manner, the mono-and di-deamidated rhGH variants were identified based on þ1 and þ2 Da mass increases for T15, respectively (Table III) . Because Asn149 and Asn152 are the only possible candidates for deamidation in T15, these amino acids must have been deamidated to aspartic acid or to isoaspartic acid (2, 3) . The rhGH trisulfide sample gave a T20-T21 complex mass of 1432 Da, corresponding to an increase of 32 Da, whereas the mass of the other disulfide complex (T6-T16) was unchanged, compared with the reference. An increase in the mass of 32 Da could also indicate two oxidations. However, the T20-T21 fragment complex does not contain any easily oxidized methionine residues, and if the cysteine residues were oxidized, the retention time of the complex would decrease due to the decreased hydrophobicity. On the contrary, the modified T20-T21 fragment complex eluted with an increased retention time, compared with the rhGH reference T20-T21 (Figure 3 ), which agrees with the findings of Andersson and co-workers (11) . Trisulfide complexes of tryptic peptides from an antibody, when compared with the corresponding disulfide complexes, also showed increased hydrophobicity and increased retention time when analyzed by RPLC (25) . The desPhe1 rhGH was identified by a 147 Da decrease in the mass of T1. The T14 (141-145, QTYSK) peak was absent in the clip sample, and instead a new small peak was generated that was eluted earlier in the chromatogram; this peak was identified as YSK (143-145) ( Figure 3 and Table III ). The dipeptide QT (141-142) from the clipped T14 was not found and may have eluted in the void peak. The LC-MS results of analysis for the intact rhGH variants and tryptic fragments demonstrated the expected mass differences, relative to the reference rhGH native form, confirming the results of the more detailed previous characterization.
Conclusion
An RP-UHPLC method has been described that allows for the rapid separation of eight rhGH variants from each other and from the native rhGH. The method was the result of method development experiments that explored the effects of temperature, mobile phase buffers and organic modifiers. The newly developed mobile phase resulted in much improved selectivity, and when combined with the UHPLC system, produced a significantly higher resolution for separating rhGH variants than previously reported RPLC methods, including pharmacopoeal methods. Characterization of the purified variants was performed by LC -MS tryptic mapping. 
